Literature DB >> 26629317

Cyclin A2: At the crossroads of cell cycle and cell invasion.

Abdelhalim Loukil1, Caroline T Cheung1, Nawal Bendris1, Bénédicte Lemmers1, Marion Peter1, Jean Marie Blanchard1.   

Abstract

Cyclin A2 is an essential regulator of the cell division cycle through the activation of kinases that participate to the regulation of S phase as well as the mitotic entry. However, whereas its degradation by the proteasome in mid mitosis was thought to be essential for mitosis to proceed, recent observations show that a small fraction of cyclin A2 persists beyond metaphase and is degraded by autophagy. Its implication in the control of cytoskeletal dynamics and cell movement has unveiled its role in the modulation of RhoA activity. Since this GTPase is involved in both cell rounding early in mitosis and later, in the formation of the cleavage furrow, this suggests that cyclin A2 is a novel actor in cytokinesis. Taken together, these data point to this cyclin as a potential mediator of cell-niche interactions whose dysregulation could be taken as a hallmark of metastasis.

Entities:  

Keywords:  Autophagy; Cyclin; Mesenchymal transition; Metastasis; Mitosis; Phospholipase C; RhoA

Year:  2015        PMID: 26629317      PMCID: PMC4657123          DOI: 10.4331/wjbc.v6.i4.346

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  26 in total

1.  ROCK and Dia have opposing effects on adherens junctions downstream of Rho.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2002-06       Impact factor: 28.824

2.  Tumor dissemination: an EMT affair.

Authors:  Jean Paul Thiery; Chwee Teck Lim
Journal:  Cancer Cell       Date:  2013-03-18       Impact factor: 31.743

3.  High-resolution live-cell imaging reveals novel cyclin A2 degradation foci involving autophagy.

Authors:  Abdelhalim Loukil; Manuela Zonca; Cosette Rebouissou; Véronique Baldin; Olivier Coux; Martine Biard-Piechaczyk; Jean-Marie Blanchard; Marion Peter
Journal:  J Cell Sci       Date:  2014-03-14       Impact factor: 5.285

Review 4.  The EMT universe: space between cancer cell dissemination and metastasis initiation.

Authors:  Luigi Ombrato; Ilaria Malanchi
Journal:  Crit Rev Oncog       Date:  2014

Review 5.  Autophagy and metabolism.

Authors:  Joshua D Rabinowitz; Eileen White
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

6.  The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation.

Authors:  Zhongjian Xie; Daniel D Bikle
Journal:  J Biol Chem       Date:  2007-01-22       Impact factor: 5.157

7.  Autophagy plays a critical role in the degradation of active RHOA, the control of cell cytokinesis, and genomic stability.

Authors:  Amine Belaid; Michaël Cerezo; Abderrahman Chargui; Elisabeth Corcelle-Termeau; Florence Pedeutour; Sandy Giuliano; Marius Ilie; Isabelle Rubera; Michel Tauc; Sophie Barale; Corinne Bertolotto; Patrick Brest; Valérie Vouret-Craviari; Daniel J Klionsky; Georges F Carle; Paul Hofman; Baharia Mograbi
Journal:  Cancer Res       Date:  2013-05-23       Impact factor: 12.701

8.  Cyclin A2, a novel regulator of EMT.

Authors:  Nawal Bendris; Caroline T Cheung; Hon Sing Leong; John D Lewis; Ann F Chambers; Jean Marie Blanchard; Bénédicte Lemmers
Journal:  Cell Mol Life Sci       Date:  2014-05-31       Impact factor: 9.261

9.  p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.

Authors:  Serhiy Pankiv; Terje Høyvarde Clausen; Trond Lamark; Andreas Brech; Jack-Ansgar Bruun; Heidi Outzen; Aud Øvervatn; Geir Bjørkøy; Terje Johansen
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

10.  A novel function for Cyclin A2: control of cell invasion via RhoA signaling.

Authors:  Nikola Arsic; Nawal Bendris; Marion Peter; Christina Begon-Pescia; Cosette Rebouissou; Gilles Gadéa; Nathalie Bouquier; Frédéric Bibeau; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  J Cell Biol       Date:  2012-01-09       Impact factor: 10.539

View more
  16 in total

1.  Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity.

Authors:  Yiyu Dong; Yongxing Gong; Fengshen Kuo; Vladimir Makarov; Ed Reznik; Gouri J Nanjangud; Omer Aras; Huiyong Zhao; Rui Qu; James A Fagin; Eric J Sherman; Bin Xu; Ronald Ghossein; Timothy A Chan; Ian Ganly
Journal:  Mol Cancer Ther       Date:  2021-11-17       Impact factor: 6.009

2.  Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas.

Authors:  Melanie Haas Kucherlapati
Journal:  Cell Cycle       Date:  2022-04-19       Impact factor: 5.173

3.  Identification of potential key genes and miRNAs involved in Hepatoblastoma pathogenesis and prognosis.

Authors:  Taha Aghajanzadeh; Kiarash Tebbi; Mahmood Talkhabi
Journal:  J Cell Commun Signal       Date:  2020-10-13       Impact factor: 5.782

4.  Cyclin A in nonfunctioning pituitary adenomas.

Authors:  Elisa B Lamback; Alexandro Guterres; Monique Alvares Barbosa; Carlos Henrique de Azeredo Lima; Debora Aparecida Silva; Aline Helen da Silva Camacho; Leila Chimelli; Leandro Kasuki; Mônica R Gadelha
Journal:  Endocrine       Date:  2020-07-03       Impact factor: 3.633

5.  Simulated Microgravity Inhibits the Proliferation of Chang Liver Cells by Attenuation of the Major Cell Cycle Regulators and Cytoskeletal Proteins.

Authors:  Chi Nguyen Quynh Ho; Minh Thi Tran; Chung Chinh Doan; Son Nghia Hoang; Diem Hong Tran; Long Thanh Le
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  Network Pharmacology-Based Approach to Investigate the Mechanisms of Hedyotis diffusa Willd. in the Treatment of Gastric Cancer.

Authors:  Xinkui Liu; Jiarui Wu; Dan Zhang; Kaihuan Wang; Xiaojiao Duan; Ziqi Meng; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-02       Impact factor: 2.629

7.  MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2.

Authors:  Qiang Ma
Journal:  Cell Mol Biol Lett       Date:  2019-02-05       Impact factor: 5.787

8.  Effects of purified Omphalia lapidescens protein on metastasis, cell cycle, apoptosis and the JAK-STAT signaling pathway in SGC-7901 human gastric cells.

Authors:  Luchao Chen; Zhongxia Lu; Yongle Yang; Lijun Du; Xiaofang Zhou; Yitao Chen
Journal:  Oncol Lett       Date:  2018-01-19       Impact factor: 2.967

9.  The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo.

Authors:  William E Samsa; Murali K Mamidi; Lindsay A Bashur; Robin Elliott; Alexander Miron; Yuqing Chen; Brendan Lee; Edward M Greenfield; Ricky Chan; David Danielpour; Guang Zhou
Journal:  Oncogene       Date:  2020-05-10       Impact factor: 9.867

10.  MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide.

Authors:  George C Bobustuc; Amin B Kassam; Richard A Rovin; Sheila Jeudy; Joshua S Smith; Beth Isley; Maharaj Singh; Ameya Paranjpe; Kalkunte S Srivenugopal; Santhi D Konduri
Journal:  Oncotarget       Date:  2018-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.